Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Cloned lines of natural killer cells

Abstract

A class of cytotoxic effector cells has recently been discovered1,2 in normal and immunodeficient nude mice that lyse a wide range of targets of both tumour and non-tumour origin. Unlike other lymphocytes, these natural killer (NK) cells are present at high levels without prior priming and have no immunological memory. Because NK cells act without prior sensitization, they could have a crucial role in immunosurveillance, providing a first defence against arising neoplastic cells. The question of NK-cell specificity is not well understood; results so far suggest that they may recognize specific antigens on their targets. Thus unlabelled competitor cells can inhibit the cytotoxic reaction of NK cells3. Furthermore, target–effector binding can be inhibited by isolated target structures4. Experiments in which the lysis of mouse and human NK-sensitive targets was competitively inhibited with target suggested that the targets recognized by NK cells are not common ones. To study this important aspect, permanent lines and clones of NK cells have been established in vitro. I report here a successful attempt to do this, and show that sublines display the same specificity spectrum as NK cells from normal cells even after recloning. This proves that antigen receptors on NK cells are not clonally distributed but leaves open the two possibilities that NK cells either recognize common structures on NK-sensitive targets or carry many receptors each with a different specificity. Cell-surface markers of NK lines distinguished them from allospecific thymus-derived lymphocyte cell lines through their lack of Lyt-1 and Lyt-2 antigen.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Roder, J. C. & Kiessling, R. Scand. J. Immun. 8, 135 (1978).

    Article  CAS  Google Scholar 

  2. Herberman, R. B. & Holden, H. T. Adv. Cancer Res. 27, 305 (1978).

    Article  CAS  Google Scholar 

  3. Kiessling, R., Klein, E. & Wigzell, H. Eur. J. Immun. 5, 112 (1975).

    Article  CAS  Google Scholar 

  4. Roder, J. C., Rosèn, A., Fenyö, E. M. & Troy, F. A. Proc. natn. Acad. Sci. U.S.A. 76, 1405 (1979).

    Article  ADS  CAS  Google Scholar 

  5. Rosenberg, S. A., Spiess, P. J. & Schwarz, S. J. Immun. 121, 1946 (1978).

    CAS  Google Scholar 

  6. Dennert, G. & Hyman, R. Eur. J. Immun. (in the press).

  7. Dennert, G. & Hyman, R. Eur. J. Immun. 7, 251 (1979).

    Article  Google Scholar 

  8. Herberman, R. B., Nunn, M. E. & Holden, H. T. J. Immun. 121, 304 (1978).

    CAS  PubMed  Google Scholar 

  9. Mattes, M. J., Sharrow, S. O., Herberman, R. B. & Holden, H. T. J. Immun. 123, 2851 (1979).

    CAS  PubMed  Google Scholar 

  10. Omary, B., Trowbridge, I. & Scheid, M. J. exp. Med. (in the press).

  11. Dennert, G. Nature 277, 476 (1979).

    Article  ADS  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dennert, G. Cloned lines of natural killer cells. Nature 287, 47–49 (1980). https://doi.org/10.1038/287047a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/287047a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing